Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck.
Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck. J Clin Oncol. 2003 May 15; 21(10):1980-7.
View in:
PubMed
subject areas
Administration, Oral
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Carcinoma, Squamous Cell
Disease-Free Survival
ErbB Receptors
Female
Head and Neck Neoplasms
Humans
Illinois
Immunohistochemistry
Intubation, Gastrointestinal
Male
Middle Aged
Mitogen-Activated Protein Kinase 3
Mitogen-Activated Protein Kinases
Neoplasm Metastasis
Neoplasm Recurrence, Local
Quinazolines
Survival Analysis
Treatment Outcome
authors with profiles
Kerstin Stenson